Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Biotech Investors Follow Pattern in Funding and Hiring Executives

Written by: Karl Simpson To be blunt, biotechnology ventures require lots of capital, and although alternative funding sources are now more accessible, money has traditionally come from the venture capital firms. These venture firms exercise differing strategies in allocating risk … Continue reading

Posted in Board Director Appointments, Executive Appointments, M&A Finance and Funding, Workplace Diversity | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Women Currently only 10% of Biotech Boards, Gender Study Shows

Authored by Karl Simpson In a new research study into gender diversity in biotech leadership, the findings convey a picture of significant male dominance in biotech boardroom. The research conducted by Liftstream, a specialist life sciences executive search practice, examined … Continue reading

Posted in Executive Appointments, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

5 Alternative Methods for assessing the potential of a new employer

Authored by Karl Simpson Below are some ideas for the contrarians among you who might assess a new job opportunity. These escape the traditional clichés and provoke you to think about why you might seek to assess jobs in a … Continue reading

Posted in Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , | Leave a comment

Genocea Biosciences secures European expertise with CFO appointment

Authored by Karl Simpson A lack of European leadership talent is often cited by investors as a limiting factor for European biotechs. Well, seemingly they are making every success of things on the other side of the Atlantic Ocean, where … Continue reading

Posted in Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Minoryx gains Orphan Drug Designation in X-Linked Adrenoleukodystrophy

Authored by Karl Simpson Nestled in the Bio-Cat cluster in Barcelona, Spain is the orphan drug therapeutics company, Minoryx Therapeutics, which is developing new medicines for the treatment of inborn errors in metabolism. The company is addressing these particular rare … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , | 1 Comment

EURORDIS recognises Orphan Europe and Swedish Orphan Biovitrum (SOBI) with awards

Authored by Karl Simpson EURORDIS (European Organisation for Rare Diseases) has handed two prestigious accolades to two European companies at the very heart of rare diseases drug development. Orphan Europe, based in Paris and part of the Recordati Group, was … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , | Leave a comment

Biosimilars – is global development a reality?

Dr Narayanan is the Managing Director of Biologicals Advice Limited. He offers independent advice on all aspects of medicine development with special expertise on biologicals, advanced therapies and biosimilars. He qualified as a medical doctor and subsequently obtained post-graduate qualifications in … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Mr Richard Bergstrom – EFPIA – Executive Leadership Series

Authored by Karl Simpson At the beginning of 2013 Liftstream profiled 13 life science leaders we believed were going to make an impact over the course of the year. Below we outline how Mr Richard Bergstrom performed for EFPIA in 2013. 2013 Liftstream Analysis: Mr Bergstorm … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

PTC Therapeutics appoints Chief Medical Officer and communicates CHMP conditional decision

Authored by Karl Simpson For patients living with Duchenne Muscular Dystrophy, last year offered great hope but also disappointment. The momentum was building in the development of exciting new therapies and they were looking forward to the promise of meaningful … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

ERYTECH makes new appointment to Board of Directors

Authored by Karl Simpson ERYTECH has announced that Vanessa Mailer will join its Board of Directors in replacement for Dr. Alain Munoz as representative of Idinvest. Vanessa Mailer is a partner with KLS Partners in Paris, a venture capital group … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap